Dr. Dorothy Auth has more than 20 years of experience in complex patent litigation, as well as licensing, patent procurement, and intellectual property counseling in the United States and abroad. Her experience spans diverse industries, including biotechnology, pharmaceutical, and medical devices, as well as consumer products, computers, and other mechanical devices.
Dorothy litigates in U.S. Federal Courts and in international arbitrations conducted under the WIPO rules. She conducts all aspects of litigation, including motion practice, expert preparation and all aspects of discovery practice.
In addition to her litigation practice, Dorothy conducts intellectual property diligence analyses for mergers, acquisitions, and bankruptcies. For example, she assisted the United States Treasury in intellectual property matters related to the restructuring of General Motors; Pfizer in intellectual property matters related to its acquisition of Wyeth; and iShares in intellectual property matters related to its potential sale. Recently, Dorothy provided IP diligence analysis to Elan Pharmaceuticals in their sale of certain assets to Biogen.
Dorothy also coordinates global patent procurement and enforcement strategies for her clients to maximize their patent-protected field. Her international experience includes coordinating patent infringement trials and hearings throughout Europe (including trials seeking preliminary relief and cross-border injunctions), as well as nullity, cancellation, and oppositions proceedings on patent rights in European courts and patent offices.
Among the clients Dorothy has represented are Medinol Ltd., DuPont Corporation, Rhone-Poulenc Rohrer, Inc., BioRest Ltd., Oscillon Ltd., Digene Corporation, Osteonics Corporation, Hoffmann-La Roche, and the National Institutes of Health.
At the firm, Dorothy is the Partner Chair of the Women's Leadership Initiative. In addition, Dorothy is a member of the Technology Committee and a member of the Advisory Counsel for the firm's Center for Career Advancement.
Dorothy is the Second Vice President of the New York Intellectual Property Law Association as well as a Board Liaison to the Patent Law Committee. She is also a member of the American Intellectual Property Association, the Conner Inn of Court and the Intellectual Property Owner's Association.
Dorothy is a frequent speaker on a wide variety of topics including:
• Strategies for Use of Post Grant Proceedings in Hatch Waxman and Follow-On Biologics Actions
• Reverse Payments and Antitrust Implications
• Patent Exhaustion in Self-Replicating Technologies
• Patent Eligible Subject Matter for Genetic Materials
• "Selecting Forum and Venue for Your Patent Litigation"
• "Chinese Patent Portfolio: A Solid, Long-Term Investment"
Prior to joining Cadwalader, she was a partner with Morgan & Finnegan, an intellectual property specialty firm in New York.
Dorothy earned her J.D. from St. John's School of Law, a Ph.D. in biochemistry from Tufts Medical School, and her B.A. from Cook College of Rutgers University.
Dorothy is admitted to practice in New York and New Jersey and before the U.S. District Courts for the Southern and Eastern Districts of New York and the District of New Jersey, and the U.S. Courts of Appeals for the Second and Federal Circuits. She is also licensed to practice before the U.S. Patent and Trademark Office.